Clinical trial Recruiting at 1 site Observational Ages 18 to 75

Link between advanced glycation end products and stomach movement problems in diabetic gastroparesis

Official title: The Role and Mechanism of SphK1/S1P/FOXO1 Axis Regulating KATP Channel Mediated Gastric Smooth Muscle Dysfunction in Diabetes Gastroparesis

Run by Northern Jiangsu People's Hospital · NCT07324785 · Data updated 2026-11-12

This project will see if levels of advanced glycation end products (AGEs) in blood and stomach tissue are linked to stomach movement problems in adults with diabetic gastroparesis.

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment50 (estimated)
SponsorNorthern Jiangsu People's Hospital
Academic / other
Locations1 site (Yangzhou, Jiangsu)
StatusRecruiting
StartedJanuary 7, 2026
Main results expectedMay 31, 2027
Study endsMay 31, 2027
Registry record updatedFebruary 17, 2026
Trial IDNCT07324785 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 to 75 who either have diagnosed diabetes with gastroparesis symptoms and can consent, or are controls aged 18 to 75 with no history of diabetes or gastroparesis symptoms and can consent.

Probably not a fit

Patients currently taking prokinetic, anticholinergic, or dopamine drugs that affect gastric motility, with prior gastrointestinal surgery, pregnancy or planning conception, neurological disorders affecting GI function (e.g., Parkinson's), or pyloric outlet obstruction are excluded and unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective observational study that collects gastric smooth muscle tissue, serum, and clinical data from adults with diabetic gastroparesis and from control participants without diabetes or gastroparesis symptoms. Researchers will compare symptom scores (Gastroparesis Cardinal Symptom Index) and electrogastrogram results between the two groups. Laboratory analyses will measure AGEs and contractile protein expression in gastric tissue and serum, and statistical tests will examine differences and correlations with clinical measures. The aim is to clarify whether tissue and serum AGE levels are associated with impaired gastric motility in diabetic patients.

Why it matters

Potential benefit: If successful, the study could clarify whether AGEs contribute to impaired gastric motility in diabetic gastroparesis and point to biomarkers or targets for future treatments.

How similar studies have gone: Prior research has linked AGEs to diabetic tissue damage and some gastrointestinal dysfunction, but direct evidence tying AGEs to gastric motility in diabetic gastroparesis is limited, so this approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria for diabetes gastroparesis group:

* Meet the diagnostic criteria for diabetes
* Presence of symptoms (see assessment of Gastroparesis Cardinal Symptom Index)
* Age range from 18 to 75 years old
* Voluntarily participate and sign an informed consent form

Inclusion Criteria for control group:

* No history of diabetes
* No symptoms (see assessment of Gastroparesis Cardinal Symptom Index)
* Age range from 18 to 75 years old
* Voluntarily participate and sign an informed consent form

Exclusion Criteria for diabetes gastroparesis group and control group:

* Currently taking prokinetic drugs, anticholinergic drugs, and dopamine drugs that may affect gastric motility
* Has a history of gastrointestinal surgery
* Pregnant or preparing to conceive
* There are neurological disorders such as Parkinson's disease that affect gastrointestinal function
* Outlet obstruction caused by organic lesions in the pylorus

Where it's running

  • Northern Jiangsu People's Hospital
    Yangzhou, Jiangsu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Online yoga for people with diabetic gastroparesis

    A virtual yoga program is being tried to see if it can help reduce gastroparesis symptoms and improve well‑being in people with diabetes.

    Recruiting Ohio State University · Columbus, Ohio · NCT07717554

  • Transplanting washed microbiota to treat diabetic gastroparesis

    This study is testing whether transplanting cleaned gut bacteria can help people with diabetic gastroparesis feel better and improve their quality of life.

    Recruiting The Second Hospital of Nanjing Medical University · Nanjing, Jiangsu · NCT06340217

  • Checking pyloric sphincter function in people with gastroparesis symptoms

    We will test whether EndoFLIP, a water‑load satiety test, and a gastric electrical test (Gastric Alimetry) can find pyloric sphincter abnormalities in adults with gastroparesis symptoms compared with people without symptoms.

    Recruiting at 5 sites Johns Hopkins Bloomberg School of Public Health · Scottsdale, Arizona and 4 other locations · NCT04661215

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.